Erratum
for
Farray et al., J Clin Oncol 23 (14) 3257-3269.
Journal of Clinical Oncology, Vol 23, No 30 (October 20), 2005: pp. 7763
© 2005 American Society of Clinical Oncology.
DOI: 10.1200/JCO.2005.09.901
ERRATUM
The May 10, 2005, article by Farray et al, entitled "Multimodality Therapy for Stage III NonSmall-Cell Lung Cancer" (J Clin Oncol 23:3257-3269, 2005) contained an error in Table 2. Under the Outcome column in the Study of RTOG 94-10, the median survival was given as 17 months for sequential, and 14.6 months for concurrent (daily RT); whereas it should have read 14.6 months for sequential, and 17 months for concurrent (daily RT).
|